These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24575510)

  • 1. Renal transplantation in a patient with catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia.
    Podolak B; Blickstein D; Inbal A; Eizner S; Rahamimov R; Yussim A; Mor E
    Isr Med Assoc J; 2014 Jan; 16(1):61-2. PubMed ID: 24575510
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.
    Wong JK; Tian Y; Shuttleworth P; Caffarelli AD; Reitz BA; Mora-Mangano CT
    Anesth Analg; 2010 Sep; 111(3):609-12. PubMed ID: 20686010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complexities of anticoagulation in the antiphospholipid syndrome.
    Levy Y; Berla M
    Isr Med Assoc J; 2014 Jan; 16(1):54-6. PubMed ID: 24575508
    [No Abstract]   [Full Text] [Related]  

  • 4. [The HEAT-PPCI study].
    Saia F; Dall'Ara G; Calabrò P
    G Ital Cardiol (Rome); 2015 Feb; 16(2):65-70. PubMed ID: 25805088
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
    White HD
    Am Heart J; 2002 Feb; 143(2):189-92. PubMed ID: 11835018
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
    Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
    J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
    Tsu LV; Dager WE
    Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 10. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of bivalirudin in the cardiac catheterization laboratory.
    Thompson KA; Philip KJ; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):140-9. PubMed ID: 21097669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts].
    Savonitto S; Morici N
    Rev Esp Cardiol; 2011 May; 64(5):361-4. PubMed ID: 21482005
    [No Abstract]   [Full Text] [Related]  

  • 16. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R
    J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
    Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
    Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
    Kiser TH; Burch JC; Klem PM; Hassell KL
    Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.